SAVA·14817C107·US·equity·Healthcare - Biotechnology-13D/G
SAVA (FILANA THERAPEUTICS INC) is held by 59 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($3.4M), TWO SIGMA INVESTMENTS, LP ($3.4M), BlackRock, Inc. ($2.4M). Net institutional sentiment: Mixed.
See how SAVA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer